• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Sofidel Builds Paper Tissue Plant in Inola, Oklahoma

Sofidel, an Italy-based paper tissue manufacturer, started construction on its 1.8-million square foot plant, near Tulsa, in Inola, Oklahoma. The company plans to invest $360 million over three years.

According to company officials, the investment includes installation of two tissue paper machines for an overall production capacity of 120,000 tons per year each, with related converting lines. The new production plant, once completed, will employ 300 full-time workers. One machine will be dedicated mainly to toilet tissue production, while the second one will be used mostly to produce towels.

"Sofidel will build a new modern, integrated plant to serve the south-central and central-western areas of this great country, where we have been operating since 2012," Luigi Lazzareschi, CEO of Sofidel Group.

"We have been growing year after year at a very fast pace," Lazzareschi added. "I would like to thank all the partners who have supported us in making this new project. They have played an integral role in helping us achieve this goal."

The company described its project as a “greenfield” investment for an integrated plant (tissue production and converting facilities) in Rogers County.

Thanks to its South-Central position in the US, the area offers well-established logistics as well as affordable sources of energy and an expert workforce, company officials said.

“I am glad to announce this new greenfield investment, the second one, after the first made in Ohio. This new investment will support our growth in the US significantly, being the American market one of the crucial ones for our Group,” Lazzareschi added.

The facilities building is expected to start in March 2018 and will be completed by second quarter of 2020, while the converting lines and the warehouse functions will be in place by the end of Q2 2019.


Exclusive Research